"the limbic" Podcast - Rheumatology advanced trainees. Navigating biologics – when to start, when to switch and how to handle the data

In this episode, join A/Prof Catherine Hill and Dr Rani Sinnathurai as they highlight a range of rheumatology resources developed as part of the Value in Prescribing bDMARDs Program. They discuss the many resources for inflammatory arthritis that are now available for rheumatologists, consumers and other health professionals. In particular, the value of key resources is featured as well as how they have been used in practice. For more information and to access these resources see: ...

Clinicians who treat vasculitis are familiar with uncertainty. In its many forms, and with no single sign, symptom or investigation strong enough to confirm a diagnosis, vasculitis presents an extensive list of challenges in a setting where diagnostic delay can lead to devastating consequences. In episode three of our Rheumatology Advanced Trainee series we deep dive into two types of vasculitis - giant cell arteritis (GCA) here in part 1 and ANCA-associated vasculitis next week in part 2. Yo...

Clinicians who treat vasculitis are familiar with uncertainty. In its many forms, and with no single sign, symptom or investigation strong enough to confirm a diagnosis, vasculitis presents an extensive list of challenges in a setting where diagnostic delay can lead to devastating consequences. In episode three of our Rheumatology Advanced Trainee series we deep dive into two types of vasculitis - giant cell arteritis (GCA) here in part 1 and ANCA-associated vasculitis next week in part 2. Yo...

In episode 2 of "The Limbic" podcast series for rheumatology advanced trainees we share a fascinating conversation on fibromyalgia with the inspiring Dr Sam Whittle, Dr Emma Guymer and Dr Richard Kwiatek. In this conversation, you’ll hear about how each practitioner has come to accept and work with the unknowns that come with a fibromyalgia diagnosis. They’ll share tips on how to talk to patients about their diagnosis, the ins and outs of working in the public and private setting,...

In this episode, Professor Debra Rowett is joined by Professor Andrew Wilson, Chair of the Pharmaceutical Benefits Advisory Committee and Dr Paul Kubler, Consultant Rheumatologist to discuss how b/tsDMARDs are funded in Australia, the policies and mechanisms that influence the cost to government and how the introduction of biosimilars affects the pricing of biologics on the PBS.